HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...

The trial will be conducted at up to seven US sites, enrolling 90 patients with advanced or metastatic solid tumours.

FibroBiologics (FBLG) announced the filing of a Phase 1/2 Investigational New Drug application with the U.S. Food and Drug Administration seeking regulatory clearance to initiate clinical trials of ...

(RTTNews) - Antengene Corporation Limited (6996.HK) announced that China National Medical Products Administration or NMPA has approved the investigational new drug application for the Phase Ib/II ...

Imagion Biosystems has submitted an Investigational New drug Application with the US FDA for its MagSense imaging agent for breast ... Read More The post Imagion Biosystems lodges IND application for ...